R&D Systems™ Recombinant Human sFRP-4 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 1827SF025

Catalog No. 1827SF025

Description

The Recombinant Human sFRP-4 Protein is derived from NS0. The Recombinant Human sFRP-4 Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.
• Molecular Weight (g/mol): 38.9 kDa
• Quantity: 25μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Conjugate: Unconjugated
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

• Gene ID (Entrez): 6424
• Name: sFRP-4
• Source: Mouse myeloma cell line,NS0-derived human sFRP-4 protein Ala22-Val346,with a C-terminal 10-His tag
• Structural Form: Recombinant Human sFRP-4 is prone to proteolytic cleavage at C-terminus, therefore the poly-His tag at C-terminus may not be present in the preparation.
• Recombinant: Recombinant